Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    10438706 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)
Condition: Acute Promyelocytic Leukemia
Intervention: Drug: AIDA
2 Completed Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: ATRA;   Drug: Idarubicina;   Drug: Mitoxantrone;   Drug: ARA-C
3 Completed APL93: Timing of CxT and Role of Maintenance
Condition: Leukemia, Promyelocytic, Acute
Interventions: Drug: ATRA;   Drug: ATRA and or Chemo as maintenance

Indicates status has not been verified in more than two years